-+ 0.00%
-+ 0.00%
-+ 0.00%

Alnylam Pharmaceuticals Price Target Cut to $250.00/Share From $455.00 by HC Wainwright & Co.

Dow Jones·11/17/2026 12:41:00

Please log in to view news